GlassScriptPhysician profile
Steven M Barone
NPI 1447407036
$6,348.49
in general payments reported to CMS, 2019-2025
32 companies · $864 in 2025
The $864 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,398 · 2020: $411 · 2021: $288 · 2022: $675 · 2023: $990 · 2024: $722 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128 · Travel and Lodging: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.79 |
| Travel and Lodging | $448.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $2,234.93 | 2019 | |
| Distalmotion US | $531.79 | 2025 | Dexter L6 Robot |
| Fujifilm Healthcare Americas Corporation | $377.32 | 2023-2024 | Fujifilm |
| Medtronic, INC. | $306.16 | 2023-2025 | Progrip, Signia |
| Thd America, INC. | $242.51 | 2021-2023 | |
| Integra Lifesciences Corporation | $240.62 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Axonics, INC. | $237.54 | 2020-2021 | |
| Boston Scientific Corporation | $231.44 | 2022 | |
| Ethicon US, LLC | $226.01 | 2020-2024 | Ethicon, Echelon Circular, Vistaseal |
| Kci USA, INC. | $213.44 | 2019-2023 | Activ.A.C., V.A.C. Dermatac |
| Conmed Corporation | $161.13 | 2020-2025 | Airseal |
| Pentax of America, INC. | $156.09 | 2023 | Inspira |
| Intuitive Surgical, INC. | $143.04 | 2020-2025 | |
| Abbvie INC. | $125.05 | 2021-2025 | Rinvoq |
| Smith+Nephew, INC. | $124.99 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $112.89 | 2019-2025 | Bridion |
| Sanara Medtech INC. | $104.89 | 2024 | Celleraterx |
| Exact Sciences Corporation | $90.60 | 2023 | Cologuard Collection Kit |
| Erbe USA INC | $90.00 | 2024 | Vio3 |
| Ferring Pharmaceuticals INC. | $61.29 | 2023 | Rebyota |
| Prodigy Surgical Distribution, INC. | $48.73 | 2024 | |
| Shire North American Group INC | $42.22 | 2019 | |
| Tela Bio, INC. | $36.66 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Braintree Laboratories, INC. | $34.07 | 2023 | Sutab, Suflave |
| Takeda Pharmaceuticals U.S.A., INC. | $31.20 | 2025 | Entyvio |
| Solventum Corporation | $30.51 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Hollister Incorporated | $30.03 | 2022 | |
| Abbott Laboratories | $20.20 | 2019 | |
| Gilead Sciences, INC. | $18.93 | 2023 | |
| Tempus Ai, INC | $14.93 | 2024 | |
| Celgene Corporation | $14.78 | 2021 | |
| Kerecis Limited | $14.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Barone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.